Safety of Voriconazole and Dose Individualization
Gespeichert in:
| Veröffentlicht in: | Clinical infectious diseases 2003-04, Vol.36 (8), p.1087-1088 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1088 |
|---|---|
| container_issue | 8 |
| container_start_page | 1087 |
| container_title | Clinical infectious diseases |
| container_volume | 36 |
| creator | Lutsar, Irja Hodges, Mike R. Tomaszewski, Konrad Troke, Peter F. Wood, Nolan D. |
| description | |
| doi_str_mv | 10.1086/374248 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1086_374248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4483443</jstor_id><oup_id>10.1086/374248</oup_id><sourcerecordid>4483443</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-c75676a919c0d962c72124f442c380febe24bb4d535dfe7913c6c24c14d31f6a3</originalsourceid><addsrcrecordid>eNp1j0tLw0AURgdRbK36C0Tixl10HnceWUq1tlBwUV90M0wmM5DaZkomFdtfbyRFV67uhXP44CB0TvANwUrcMgkU1AHqE85kKnhGDtsfc5WCYqqHTmJcYEyIwvwY9QgVCjKq-ojMjHfNNgk-eQ11aUNldmHpElMVyX2ILplURflZFhuzLHemKUN1io68WUZ3tr8D9DJ6eB6O0-nT42R4N00tcNWkVnIhhclIZnGRCWolJRQ8ALVMYe9yRyHPoeCMF97JjDArLAVLoGDEC8MG6LrbtXWIsXZer-tyZeqtJlj_NOuuuRUvO3G9yVeu-NP2ka1w1Qlhs_5_5KJzFrEJ9a8FLQJgLU47XMbGff1iU39oIZnkevw-17O30VyMMOgh-wZacHI4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Safety of Voriconazole and Dose Individualization</title><source>Jstor Complete Legacy</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Lutsar, Irja ; Hodges, Mike R. ; Tomaszewski, Konrad ; Troke, Peter F. ; Wood, Nolan D.</creator><creatorcontrib>Lutsar, Irja ; Hodges, Mike R. ; Tomaszewski, Konrad ; Troke, Peter F. ; Wood, Nolan D.</creatorcontrib><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/374248</identifier><identifier>PMID: 12684928</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Antifungal Agents - administration & dosage ; Antifungal Agents - adverse effects ; Antifungal Agents - pharmacokinetics ; Aspergillosis ; Azoles ; Candidiasis ; Correspondence ; Dosage ; Humans ; Immunocompromised Host ; Infectious diseases ; Liver Function Tests ; Neutropenia ; Phosphatases ; Pyrimidines - administration & dosage ; Pyrimidines - adverse effects ; Pyrimidines - pharmacokinetics ; Triazoles - administration & dosage ; Triazoles - adverse effects ; Triazoles - pharmacokinetics ; Voriconazole</subject><ispartof>Clinical infectious diseases, 2003-04, Vol.36 (8), p.1087-1088</ispartof><rights>Copyright 2003 The Infectious Diseases Society of America</rights><rights>2003 by the Infectious Diseases Society of America 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-c75676a919c0d962c72124f442c380febe24bb4d535dfe7913c6c24c14d31f6a3</citedby><cites>FETCH-LOGICAL-c458t-c75676a919c0d962c72124f442c380febe24bb4d535dfe7913c6c24c14d31f6a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4483443$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4483443$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12684928$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lutsar, Irja</creatorcontrib><creatorcontrib>Hodges, Mike R.</creatorcontrib><creatorcontrib>Tomaszewski, Konrad</creatorcontrib><creatorcontrib>Troke, Peter F.</creatorcontrib><creatorcontrib>Wood, Nolan D.</creatorcontrib><title>Safety of Voriconazole and Dose Individualization</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><subject>Antifungal Agents - administration & dosage</subject><subject>Antifungal Agents - adverse effects</subject><subject>Antifungal Agents - pharmacokinetics</subject><subject>Aspergillosis</subject><subject>Azoles</subject><subject>Candidiasis</subject><subject>Correspondence</subject><subject>Dosage</subject><subject>Humans</subject><subject>Immunocompromised Host</subject><subject>Infectious diseases</subject><subject>Liver Function Tests</subject><subject>Neutropenia</subject><subject>Phosphatases</subject><subject>Pyrimidines - administration & dosage</subject><subject>Pyrimidines - adverse effects</subject><subject>Pyrimidines - pharmacokinetics</subject><subject>Triazoles - administration & dosage</subject><subject>Triazoles - adverse effects</subject><subject>Triazoles - pharmacokinetics</subject><subject>Voriconazole</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1j0tLw0AURgdRbK36C0Tixl10HnceWUq1tlBwUV90M0wmM5DaZkomFdtfbyRFV67uhXP44CB0TvANwUrcMgkU1AHqE85kKnhGDtsfc5WCYqqHTmJcYEyIwvwY9QgVCjKq-ojMjHfNNgk-eQ11aUNldmHpElMVyX2ILplURflZFhuzLHemKUN1io68WUZ3tr8D9DJ6eB6O0-nT42R4N00tcNWkVnIhhclIZnGRCWolJRQ8ALVMYe9yRyHPoeCMF97JjDArLAVLoGDEC8MG6LrbtXWIsXZer-tyZeqtJlj_NOuuuRUvO3G9yVeu-NP2ka1w1Qlhs_5_5KJzFrEJ9a8FLQJgLU47XMbGff1iU39oIZnkevw-17O30VyMMOgh-wZacHI4</recordid><startdate>20030415</startdate><enddate>20030415</enddate><creator>Lutsar, Irja</creator><creator>Hodges, Mike R.</creator><creator>Tomaszewski, Konrad</creator><creator>Troke, Peter F.</creator><creator>Wood, Nolan D.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20030415</creationdate><title>Safety of Voriconazole and Dose Individualization</title><author>Lutsar, Irja ; Hodges, Mike R. ; Tomaszewski, Konrad ; Troke, Peter F. ; Wood, Nolan D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-c75676a919c0d962c72124f442c380febe24bb4d535dfe7913c6c24c14d31f6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Antifungal Agents - administration & dosage</topic><topic>Antifungal Agents - adverse effects</topic><topic>Antifungal Agents - pharmacokinetics</topic><topic>Aspergillosis</topic><topic>Azoles</topic><topic>Candidiasis</topic><topic>Correspondence</topic><topic>Dosage</topic><topic>Humans</topic><topic>Immunocompromised Host</topic><topic>Infectious diseases</topic><topic>Liver Function Tests</topic><topic>Neutropenia</topic><topic>Phosphatases</topic><topic>Pyrimidines - administration & dosage</topic><topic>Pyrimidines - adverse effects</topic><topic>Pyrimidines - pharmacokinetics</topic><topic>Triazoles - administration & dosage</topic><topic>Triazoles - adverse effects</topic><topic>Triazoles - pharmacokinetics</topic><topic>Voriconazole</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lutsar, Irja</creatorcontrib><creatorcontrib>Hodges, Mike R.</creatorcontrib><creatorcontrib>Tomaszewski, Konrad</creatorcontrib><creatorcontrib>Troke, Peter F.</creatorcontrib><creatorcontrib>Wood, Nolan D.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lutsar, Irja</au><au>Hodges, Mike R.</au><au>Tomaszewski, Konrad</au><au>Troke, Peter F.</au><au>Wood, Nolan D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety of Voriconazole and Dose Individualization</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2003-04-15</date><risdate>2003</risdate><volume>36</volume><issue>8</issue><spage>1087</spage><epage>1088</epage><pages>1087-1088</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>12684928</pmid><doi>10.1086/374248</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 2003-04, Vol.36 (8), p.1087-1088 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_crossref_primary_10_1086_374248 |
| source | Jstor Complete Legacy; Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Antifungal Agents - administration & dosage Antifungal Agents - adverse effects Antifungal Agents - pharmacokinetics Aspergillosis Azoles Candidiasis Correspondence Dosage Humans Immunocompromised Host Infectious diseases Liver Function Tests Neutropenia Phosphatases Pyrimidines - administration & dosage Pyrimidines - adverse effects Pyrimidines - pharmacokinetics Triazoles - administration & dosage Triazoles - adverse effects Triazoles - pharmacokinetics Voriconazole |
| title | Safety of Voriconazole and Dose Individualization |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T22%3A26%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20of%20Voriconazole%20and%20Dose%20Individualization&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Lutsar,%20Irja&rft.date=2003-04-15&rft.volume=36&rft.issue=8&rft.spage=1087&rft.epage=1088&rft.pages=1087-1088&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1086/374248&rft_dat=%3Cjstor_cross%3E4483443%3C/jstor_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12684928&rft_jstor_id=4483443&rft_oup_id=10.1086/374248&rfr_iscdi=true |